Phase II trial and cost analysis of fazarabine in advanced non-small cell carcinoma of the lung: A southwest oncology group study

Stephen K. Williaon, John J. Crowley, Robert B. Livingston, Timothy J. Panella, John Wendall Goodwin

Research output: Contribution to journalArticlepeer-review

21 Scopus citations

Fingerprint

Dive into the research topics of 'Phase II trial and cost analysis of fazarabine in advanced non-small cell carcinoma of the lung: A southwest oncology group study'. Together they form a unique fingerprint.

Medicine & Life Sciences